logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 8697647 B1

PDFFull Text
Expired
Date of Patent:
Apr. 15, 2014

Filed:

Dec. 12, 2011

Hybrid polypeptides with selectable properties

Applicants:

Odile Esther Levy, San Diego, CA (US);

Michael R. Hanley, Corte Madera, CA (US);

Carolyn M. Jodka, Encinitas, CA (US);

Diana Y. Lewis, San Diego, CA (US);

Christopher J. Soares, La Jolla, CA (US);

Soumitra S. Ghosh, San Diego, CA (US);

Lawrence J. D'souza, San Diego, CA (US);

David G. Parkes, Del Mar, CA (US);

Christine M. Mack, Camarillo, CA (US);

Inventors:

Odile Esther Levy, San Diego, CA (US);

Michael R. Hanley, Corte Madera, CA (US);

Carolyn M. Jodka, Encinitas, CA (US);

Diana Y. Lewis, San Diego, CA (US);

Christopher J. Soares, La Jolla, CA (US);

Soumitra S. Ghosh, San Diego, CA (US);

Lawrence J. D'Souza, San Diego, CA (US);

David G. Parkes, Del Mar, CA (US);

Christine M. Mack, Camarillo, CA (US);

Assignee:

Other;

Attorney:

Kilpatrick Townsend & Stockton LLP

Primary Examiner:

Gyan Chandra

Int. Cl.
CPC ...
A61K 38/00 (2006.01); A61K 38/26 (2006.01);
U.S. Cl.
CPC ...
Abstract

The present invention relates generally to novel, selectable hybrid polypeptides useful as agents for the treatment and prevention of metabolic diseases and disorders which can be alleviated by control plasma glucose levels, insulin levels, and/or insulin secretion, such as diabetes and diabetes-related conditions. Such conditions and disorders include, but are not limited to, hypertension, dyslipidemia, cardiovascular disease, eating disorders, insulin-resistance, obesity, and diabetes mellitus of any kind, including type 1, type 2, and gestational diabetes.

Find Patent Forward Citations

Levy, Odile. (2014). Hybrid polypeptides with selectable properties (U.S. Patent No. 8697647). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/8697647

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…